MODULATING INSULIN RECEPTOR SIGNALING

Details for Australian Patent Application No. 2002245258 (hide)

Owner EXELIXIS, INC.

Inventors SEIDEL-DUGAN, Cynthia; FERGUSON, Kimberly, Carr; KIDD, Thomas

Pub. Number AU-A-2002245258

PCT Pub. Number WO2002/055664

Priority 60/261,335 12.01.01 US; 60/261,532 12.01.01 US; 60/261,590 12.01.01 US; 60/261,361 12.01.01 US; 60/261,531 12.01.01 US; 60/261,457 12.01.01 US; 60/261,694 12.01.01 US; 60/261,226 12.01.01 US; 60/261,304 12.01.01 US; 60/261,459 12.01.01 US; 60/261,456 12.01.01 US; 60/261,589 12.01.01 US; 60/261,461 12.01.01 US; 60/261,697 12.01.01 US; 60/261,458 12.01.01 US; 60/261,695 12.01.01 US; 60/261,336 12.01.01 US; 60/261,518 12.01.01 US; 60/261,303 12.01.01 US

Filing date 11 January 2002

Wipo publication date 24 July 2002

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002245258

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245259-ENCODING AND SENSING OF SYRINGE INFORMATION

2002245257-SREBP PATHWAY MODULATION THROUGH TARGETING HISRS